Failure patterns and clinical indications in early-stage follicular lymphoma: a study from the National Cancer Center in China
Patients with early-stage FL in this 20-year real-world Chinese cohort demonstrated an overall favorable long-term prognosis across diverse initial management strategies. No treatment modality showed a clear survival advantage in this limited-size cohort, while relapse was uncommon and more frequently locoregional than systemic. POD24 identified a small subset of patients with inferior survival, highlighting the need for individualized, risk-adapted management and long-term follow-up.
Authors
- Shijie Yang
- T. Wu
- Chunqiang Xu (ORCID: https://orcid.org/0000-0002-2564-2689)
- J. Jin
- Hao Jing
- Wen-wen Zhang
- Xin Liu
- Yong Yang
- Hui Fang
- Yue Liu
- Jingru Zhu
- Yunpeng Wu
- Yuan Tang
- Shu-Lian Wang
- Shu-Nan Qi
- Ye-Xiong Li
- Ning Li
- Qiu-Zi Zhong
- Ning-Ning Lu
- Si-Ye Chen
- Yong-Wen Song
- Bo Chen
- Yue-Ping Liu
Institutions
- Fujian Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Geriatric Hospital (CN)
- Guizhou Cancer Hospital (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- Beijing Hospital (CN)
- National Clinical Research (US)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-14
- DOI
- https://doi.org/10.3389/fphar.2026.1745000
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00